Page last updated: 2024-08-24

ranolazine and Precordial Catch

ranolazine has been researched along with Precordial Catch in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balla, C; Ferrari, R; Pavasini, R	1
Cossarini, F; Kumthekar, A; Massera, D; Shih, JC; Taub, CC	1

Reviews

1 review(s) available for ranolazine and Precordial Catch

Article	Year
Treatment of Angina: Where Are We? Cardiology, 2018, Volume: 140, Issue:1 Topics: Adrenergic beta-Antagonists; Angina, Stable; Calcium Channel Blockers; Cardiovascular Agents; Chest Pain; Humans; Ivabradine; Nicorandil; Patient Selection; Practice Guidelines as Topic; Ranolazine; Treatment Outcome; Trimetazidine	2018

Other Studies

2 other study(ies) available for ranolazine and Precordial Catch

Article	Year
Ranolazine-induced Repolarization Changes: A Case Report. The American journal of medicine, 2015, Volume: 128, Issue:7 Topics: Acetanilides; Action Potentials; Chest Pain; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Electrocardiography; Female; Follow-Up Studies; Heart Conduction System; Humans; Long QT Syndrome; Middle Aged; Piperazines; Ranolazine; Risk Assessment; Sodium Channel Blockers; Stents; Takotsubo Cardiomyopathy	2015
FDA okays new drug for tough-to-treat chest pain. Harvard heart letter : from Harvard Medical School, 2006, Volume: 16, Issue:8 Topics: Acetanilides; Angina Pectoris; Chest Pain; Drug Approval; Enzyme Inhibitors; Humans; Piperazines; Ranolazine; United States; United States Food and Drug Administration	2006

Article

Year

Ranolazine-induced Repolarization Changes: A Case Report.

The American journal of medicine, 2015, Volume: 128, Issue:7

Topics: Acetanilides; Action Potentials; Chest Pain; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Electrocardiography; Female; Follow-Up Studies; Heart Conduction System; Humans; Long QT Syndrome; Middle Aged; Piperazines; Ranolazine; Risk Assessment; Sodium Channel Blockers; Stents; Takotsubo Cardiomyopathy

2015

FDA okays new drug for tough-to-treat chest pain.

Harvard heart letter : from Harvard Medical School, 2006, Volume: 16, Issue:8

Topics: Acetanilides; Angina Pectoris; Chest Pain; Drug Approval; Enzyme Inhibitors; Humans; Piperazines; Ranolazine; United States; United States Food and Drug Administration

2006